Failure to Register and List
Similar Posts
Pharmaceutical Quality Resources
FDA provides resources on pharmaceutical quality topics, including information on regulations, guidance documents, and compliance programs.CDER Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality (CDER Quality Standards Program)
CDER Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality (CDER Quality Standards Program)Draft pageFDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients
The U.S. Food and Drug Administration today established a “green list” import alert to help stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) from unverified foreign sources from entering the U.S. market.Delta Pharma Inc. Ripley, MS. 483 issued 11/21/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/21/2025
Short Title (70 char) Delta Pharma Inc. Ripley, MS. 483 issued 11/21/2025
FEI Number 3004034796
Firm Name Delta Pharma Inc
Record Type 483
State MS
Establishment Type Outsourcing FacilityFDA alerts drug manufacturers to the risk of benzene contamination in certain drugs
FDA is evaluating the root cause of benzene contamination in certain drugs and alerting drug manufacturers to the risk of benzene contamination from drug components and other potential risk factorsCaraco Pharmaceutical Laboratories. Recall Enterprise System (RES)Digoxin Recall Details
Caraco Pharmaceutical Laboratories. Recall Enterprise System (RES) recall details